Your Source for Venture Capital and Private Equity Financings

SmithRx Announces $20 Million Series B

2022-03-11
SAN FRANCISCO, CA, SmithRx, a pharmacy benefits management company, announced the closing of a $20 million series B financing round led by Venrock.
SmithRx, a pharmacy benefits management company, announced the closing of a $20 million series B financing round. Venrock led the oversubscribed round and was joined by existing investors, including Founders Fund.

SmithRx reduces total drug costs and improves health outcomes with 100% pass-through pricing and the world's most advanced PBM technology. With hundreds of broker and TPA partners, SmithRx has simplified pharmacy benefits with its leading-edge technology and easily-integrated cloud infrastructure, resulting in lower pharmacy costs for employers.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading